Literature DB >> 4345046

Specific estrogen-binding capacity of the cytoplasmic receptor in normal and neoplastic breast tissues of humans.

J L Wittliff, R Hilf, W F Brooks, E D Savlov, T C Hall, R A Orlando.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4345046

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  16 in total

1.  Oestrogen receptors in breast cancer: a changing concept.

Authors:  G Leclercq; J C Heuson; M C Deboel; W H Mattheiem
Journal:  Br Med J       Date:  1975-01-25

2.  Multiple steroid receptors in human breast cancer. II. Estrogen and progestin receptors in 672 primary tumors.

Authors:  P M Martin; P H Rolland; J Jacquemier; A M Rolland; M Toga
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

3.  Correlation of aromatase activity with histological differentiation of breast cancer--a morphometric analysis.

Authors:  A Lipton; R J Santen; S J Santner; H A Harvey; D White-Hershey; M J Bartholomew; F E Sharkey
Journal:  Breast Cancer Res Treat       Date:  1988-09       Impact factor: 4.872

4.  In vitro estrogen-binding by human breast carcinomas.

Authors:  B G Mobbs; I E Johnson
Journal:  Can Med Assoc J       Date:  1976-02-07       Impact factor: 8.262

5.  Breast carcinoma cellularity and its relation to oestrogen receptor content.

Authors:  D M Parham; P R Baker; A J Robertson; A Vasishta; P G Baker; G Smith
Journal:  J Clin Pathol       Date:  1989-11       Impact factor: 3.411

6.  Multiple steroid receptors in human breast cancer. III. Relationships between steroid receptors and the state of differentiation and the activity of carcinomas throughout the pathologic features.

Authors:  P M Martin; P H Rolland; J Jacquemier; A M Rolland; M Toga
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

7.  Steroid hormone receptors in human melanoma.

Authors:  H J Grill; P Benes; B Manz; P Schramm; B Morsches; G W Korting; K Pollow
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

Review 8.  ER re-expression and re-sensitization to endocrine therapies in ER-negative breast cancers.

Authors:  Joeli A Brinkman; Dorraya El-Ashry
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-03-05       Impact factor: 2.673

9.  Antioestrogens in treatment of breast cancer: value of nafoxidine in 52 advanced cases.

Authors:  H J Bloom; E Boesen
Journal:  Br Med J       Date:  1974-04-06

10.  Steroid hormone receptors and prognosis in breast cancer.

Authors:  G Daxenbichler; E P Forsthuber; C Marth; G Kemmler; J Wiegele; R Margreiter; L Müller; H Hausmaninger; D Manfreda; O Dapunt
Journal:  Breast Cancer Res Treat       Date:  1988-12       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.